Evidence map›Paper›PMID 33020913›Full record

ArticleAllergy2021

Identification of Pru du 6 as a potential marker allergen for almond allergy.

Stefan Kabasser, Christine Hafner, Sharon Chinthrajah, Sayantani B Sindher, Divya Kumar, Laurie E Kost, Andrew J Long, Kari C Nadeau, Heimo Breiteneder, Merima Bublin

Open access · hybridAbstract read
In one paragraph

Article in Allergy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Pru du 1, the BetClinical and translational allergy · 2022
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Stefan KabasserCenter of Pathophysiology, Infectiology and Immunology, Institute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
Christine HafnerDepartment of Dermatology, University Hospital St. Poelten, Karl Landsteiner University of Health Sciences, St. Poelten, Austria.
Sharon ChinthrajahSean N. Parker Center for Allergy and Asthma Research, Stanford University, Stanford, CA, USA.ORCID 0000-0003-2467-4256
Sayantani B SindherSean N. Parker Center for Allergy and Asthma Research, Stanford University, Stanford, CA, USA.
Divya KumarSean N. Parker Center for Allergy and Asthma Research, Stanford University, Stanford, CA, USA.
Laurie E KostSean N. Parker Center for Allergy and Asthma Research, Stanford University, Stanford, CA, USA.
Andrew J LongSean N. Parker Center for Allergy and Asthma Research, Stanford University, Stanford, CA, USA.
Kari C NadeauSean N. Parker Center for Allergy and Asthma Research, Stanford University, Stanford, CA, USA.ORCID 0000-0002-2146-2955
Heimo BreitenederCenter of Pathophysiology, Infectiology and Immunology, Institute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.ORCID 0000-0003-2022-8689
Merima BublinCenter of Pathophysiology, Infectiology and Immunology, Institute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-7191-9431
Stanford University · USMedical University of Vienna · ATKarl Landsteiner University of Health Sciences · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOral food challenges have demonstrated that diagnosis of almond allergy based on extract-sIgE tests displays low specificity. Molecular allergy diagnosis is expected to improve accuracy, but its value in diagnosing almond allergy remains unknown. The aim of this study was to identify relevant almond allergens and examine their ability to improve almond allergy diagnosis.

methodsIgE-reactive proteins were purified from almond kernels. IgE binding to almond extract and the allergens was analyzed by quantitative ELISA using sera from 18 subjects with a proven almond allergy. The control group consisted of sera from 18 subjects allergic to peanut and/or tree nuts but tolerant to almond.

resultsThree IgE-binding proteins were identified: legumin (Pru du 6), alpha-hairpinin (Pru du 8), and mandelonitrile lyase (Pru du 10). Positive IgE (≥0.35 kU/L) to almond extract showed 94% sensitivity but only 33% specificity. IgE to Pru du 6 maintained high sensitivity (83%) and provided superior specificity (78%). Sera from almond-allergic subjects had significantly higher IgE levels to almond extract (P < .0001) and Pru du 6 (P < .0001) than sera from tolerant donors. Sensitization to Pru du 6 was highly specific for almond allergy, while frequencies of sensitization to legumins from peanut, walnut, hazelnut, and cashew were similar in both groups. IgE to Pru du 8 and Pru du 10 was less sensitive (41% and 67%), but showed specificities of 100% and 61%.

conclusionThe use of almond allergens markedly increases the diagnostic specificity compared to the extract. Pru du 6 is a potential new molecular marker for almond allergy.

Indexed as

Antigens, PlantPlant ProteinsPrunus dulcisAllergensArachisFood HypersensitivityHumansImmunoglobulin EAllergensAntigens, PlantImmunoglobulin EPlant Proteinsalmond allergensdiagnostic specificityfood allergymolecular allergy diagnosistree nut allergy

Identifiers

PMID33020913
PMCPMC8247360
OpenAlexW3090377049

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.